Search research articles
Contact Us
Filters
Showing results (11-20 of 127) with videos related to
Page
of 13
Sort By:
Lancet (London, England)
|
May 3, 2003
P2X7 polymorphism and chronic lymphocytic leukaemia
Constantine S Mitsiades, Nicholas Mitsiades
Current Opinion in Investigational Drugs (London, England : 2000)
|
July 10, 2004
CC-5013 (Celgene)
Constantine S Mitsiades, Nicholas Mitsiades
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 2, 2008
Molecular pathology of thyroid cancer: diagnostic and clinical implications
James A Fagin, Nicholas Mitsiades
Expert Review of Anticancer Therapy
|
December 14, 2011
Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer
Diego J Bedoya, Nicholas Mitsiades
Current Cancer Drug Targets
|
May 12, 2004
The Akt pathway: molecular targets for anti-cancer drug development
Constantine S Mitsiades, Nicholas Mitsiades, Michael Koutsilieris
Cancer Cell
|
November 16, 2004
Focus on multiple myeloma
Constantine S Mitsiades, Nicholas Mitsiades, Nikhil C Munshi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 15, 2003
Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines
Constantine S Mitsiades, Despoina Sykoutri, Ciaran McMullan, et al.
Seminars in Oncology
|
April 30, 2003
Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias
Constantine S Mitsiades, Nicholas Mitsiades, Steven P Treon, et al.
Seminars in Oncology
|
November 26, 2008
Cognitive effects of hormonal therapy in older adults
Nicholas Mitsiades, Denise Correa, Cary P Gross, et al.
Blood
|
March 6, 2002
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells
Nicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 127) with videos related to
Sort By:
Page
of 13
Lancet (London, England)
|
May 3, 2003
P2X7 polymorphism and chronic lymphocytic leukaemia
Constantine S Mitsiades, Nicholas Mitsiades
Current Opinion in Investigational Drugs (London, England : 2000)
|
July 10, 2004
CC-5013 (Celgene)
Constantine S Mitsiades, Nicholas Mitsiades
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 2, 2008
Molecular pathology of thyroid cancer: diagnostic and clinical implications
James A Fagin, Nicholas Mitsiades
Expert Review of Anticancer Therapy
|
December 14, 2011
Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer
Diego J Bedoya, Nicholas Mitsiades
Current Cancer Drug Targets
|
May 12, 2004
The Akt pathway: molecular targets for anti-cancer drug development
Constantine S Mitsiades, Nicholas Mitsiades, Michael Koutsilieris
Cancer Cell
|
November 16, 2004
Focus on multiple myeloma
Constantine S Mitsiades, Nicholas Mitsiades, Nikhil C Munshi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 15, 2003
Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines
Constantine S Mitsiades, Despoina Sykoutri, Ciaran McMullan, et al.
Seminars in Oncology
|
April 30, 2003
Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias
Constantine S Mitsiades, Nicholas Mitsiades, Steven P Treon, et al.
Seminars in Oncology
|
November 26, 2008
Cognitive effects of hormonal therapy in older adults
Nicholas Mitsiades, Denise Correa, Cary P Gross, et al.
Blood
|
March 6, 2002
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells
Nicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
Page
of 13